Treatment Approach for Adults with ADHD and GAD

First-Line Treatment Strategy

The American Academy of Child and Adolescent Psychiatry recommends starting with a long-acting stimulant medication, such as methylphenidate or amphetamine, as first-line treatment for ADHD, as stimulants frequently improve both ADHD symptoms and comorbid anxiety symptoms, and anxiety is not a contraindication to stimulant use 1, 2
Long-acting formulations of stimulants are strongly preferred for adults with ADHD due to better adherence, lower rebound effects, and consistent symptom control throughout the day 2
Amphetamine-based stimulants are preferred for adults based on comparative efficacy studies, though methylphenidate is also highly effective 2
Stimulants demonstrate large effect sizes and rapid onset of action, typically within hours of administration 1
The presence of GAD does not contraindicate stimulant use - stimulants can directly improve executive function deficits by enhancing dopamine and norepinephrine in prefrontal cortex networks, which can indirectly reduce anxiety related to functional impairment 2

The American Academy of Child and Adolescent Psychiatry recommends obtaining baseline blood pressure, pulse, height, and weight before initiating treatment 3
Regular vital sign monitoring (blood pressure and pulse) is necessary with stimulant use, checked quarterly 3, 2
Track anxiety symptoms carefully to ensure GAD is not worsening, though this is uncommon 2
Monitor for decreased appetite, insomnia, and headache as common side effects 1

Atomoxetine requires 6-12 weeks to achieve full therapeutic effect, unlike stimulants 4, 1
Can be dosed once daily or split into morning and evening doses to reduce side effects 4

Extended-release guanfacine or clonidine (alpha-2 adrenergic agonists) can be used as monotherapy or adjunctive therapy 5, 2
These have effect sizes around 0.7 and require 2-4 weeks to develop therapeutic effect 4, 5
Guanfacine dosing: 1-4 mg once daily, adjusted to body weight (approximately 0.1 mg/kg) 5
Common side effects include somnolence, fatigue, irritability, and potential cardiovascular effects (hypotension, bradycardia) 5
Evening administration is generally preferable due to sedative effects 4

Avoid stimulants if the patient has previous sensitivity to stimulant medications, symptomatic cardiovascular disease, hyperthyroidism or uncontrolled hypertension, active psychotic disorder, current use of MAO inhibitors, or history of stimulant abuse (unless in controlled setting) 3